BioE seeks FDA approval for cord blood device

11/28/2007 | Star Tribune (Minneapolis-St. Paul, Minn.)

BioE has applied for FDA approval to market its PrepaCyte-CB system, a device used in collecting and separating stem cells from human umbilical cord blood. The device could help cord blood banks improve their processing techniques and protocols, a BioE executive said.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA